Patents by Inventor Janyra Espinoza

Janyra Espinoza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY-DNA CONJUGATES AND HPV DETECTION AND TREATMENT
    Publication number: 20220290262
    Abstract: The present disclosure related to a method of detecting a molecule using an antibody-DNA conjugate, and pharmaceutical compositions comprising new polypeptides and use thereof.
    Type: Application
    Filed: January 24, 2020
    Publication date: September 15, 2022
    Applicant: PSOMAGEN INC.
    Inventors: Zachary Apte, Jessica Richman, Daniel Almonacid, Janyra Espinoza, Mario Saavedra
  • Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide
    Patent number: 11424006
    Abstract: Embodiments of a method and/or system can include administering, to a patient with one or more conditions associated with at least one of TMA, TMAO, and/or derivatives thereof, a therapeutically effective amount of a compound for affecting inhibiting one or more CutC enzymes and/or CntA enzymes associated with microorganisms from at least one taxon from a set of microorganism taxa.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: August 23, 2022
    Assignee: Psomagen, Inc.
    Inventors: Zachary Apte, Jessica Richman, Daniel Almonacid, Valeria Marquez, Ingrid Araya, Melissa Alegria, Mario Saavedra, Luis Gomez, Janyra Espinoza, Javier Gimpel, Eduardo Morales, Rodrigo Ortiz
  • TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE
    Publication number: 20210128498
    Abstract: Embodiments of a method and/or system can include administering, to a patient with one or more conditions associated with at least one of TMA, TMAO, and/or derivatives thereof, a therapeutically effective amount of a compound for affecting inhibiting one or more CutC enzymes and/or CntA enzymes associated with microorganisms from at least one taxon from a set of microorganism taxa.
    Type: Application
    Filed: August 14, 2018
    Publication date: May 6, 2021
    Inventors: Zachary APTE, Jessica RICHMAN, Daniel ALMONACID, Valeria MARQUEZ, Ingrid ARAYA, Melissa ALEGRIA, Mario SAAVEDRA, Luis GOMEZ, Janyra ESPINOZA, Javier GIMPEL, Eduardo MORALES, Rodrigo ORTIZ
  • RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES
    Publication number: 20190050525
    Abstract: Embodiments of a method and/or system can include administering, to a patient with one or more conditions associated with at least one of TMA, TMAO, and/or derivatives thereof, a therapeutically effective amount of a compound for affecting inhibiting one or more CutC enzymes and/or CntA enzymes associated with microorganisms from at least one taxon from a set of microorganism taxa.
    Type: Application
    Filed: August 14, 2018
    Publication date: February 14, 2019
    Inventors: Zachary Apte, Jessica Richman, Daniel Almonacid, Valeria Marquez, Ingrid Araya, Melissa Alegria, Mario Saavedra, Luis Gomez, Janyra Espinoza, Javier Gimpel, Eduardo Morales, Rodrigo Ortiz